Back

Prognostic factors and outcomes in patients under 75 years old receiving transcatheter aortic valve implantation: insights from the LAPLACE registry

30 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Predicting outcomes after TAVI Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Assistant Professor Ryotaro Matsuo

Juntendo University Graduate School of Medicine, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Clinical clustering TAVI patients: multivariate analysis of risk factors, clinical presentation, profiling and outcome association using a two-step cluster analysis
Mr A. Rocha De Almeida (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Periprocedural changes in an AI-based ECG model predict post-TAVR clinical outcomes
Doctor M. Segar (Houston, US)
Abstract Slides Video
Presentation thumbnail
Factors associated with futility in transcatheter aortic valve replacement: a single-center analysis
Doctor C. Nuevo-Gallardo (Badajoz, ES)
Abstract Slides Video
Presentation thumbnail
Distinct features of predictive profiles for poor functional improvement and mortality after TAVR. Incremental value of 6-minute walk test
Doctor J. Rychlewski (Wroclaw, PL)
Abstract Slides Video
Presentation thumbnail
Outcomes of transcatheter aortic valve implantation in young low-risk patients: a comprehensive meta-analysis of efficacy and safety
Mr A. Rocha De Almeida (Evora, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting outcomes after TAVI

The Event

Event poster

ESC Congress 2025

30 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Real-world outcome and long-term survival analysis after trans-catheter aortic valve implantation (TAVI) - does age matter?
thumbnail
Congress Session
Transcatheter aortic valve implantation topical challenges
thumbnail
Congress Session
Improving prognosis after TAVI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources